Navigation Links
Barrier (Filter) Tips, 200 l size

ProductsBarrier (Filter) Tips, 200 l size
Company Ambion, Inc.
Item Barrier (Filter) Tips, 200 l size
Features Inquire
Description Ambion's barrier tips prevent cross-contamination of samples by means of an aerosol filter. They are RNase- and DNase-free and are ideal for handling RNA, PCR applications, and for working with radioisotopes or toxic chemicals.
Info Ambion, Inc.
Customer Service: 800.888.8804
Web site: http://www.ambion.com/

Related medicine products :

1. MEDPOR Barrier Miniplate Channel Implant
2. STERILE VIEW Barrier Sleeves
3. Center Mounted Barriers
4. Protective Curtain For Barriers
5. RayShield Frame Mounted Overhead Lead Acrylic Barriers
6. Height-Adjustable Mobile X-Ray Barrier
7. Mobile Barrier
8. Full-Height Radiation Barriers
9. Clear Pb Mobile Barriers
10. MarShields Lead Radiation Shields & Barriers
11. Regular Barrier
(Date:1/8/2009)...rrorist Missile Strikes , , NEW YORK, Jan. 8 /...s (UJC) and the Jewish Federations of North Americ...humanitarian and social needs in southern Israel, ... solidarity with Israelis during the current confl...rol of the Gaza Strip. , , The funds will enha...
(Date:1/8/2009)...an. 8 The National eHealth Collabo...nced the results of its organizational leadership ... CEO of Prematics, Inc., was elected to serve as V...ctors. The Collaborative builds on the accomplish... (AHIC), a federal advisory committee established ...
(Date:1/8/2009)... Jan 8 Wyeth (NYSE: WY... Morgan Healthcare Conference on Wednesday, Januar... for Wyeth will be Geno Germano, President, U.S. a...icals. , , Wyeth,s presentation will be webcas...ble for replay following the conference. , , Wy...
(Date:1/8/2009)... Ripa Will Be Celebrity Host of Show at Nassau Col...nd Up for a Cure today announced the first of its...h Barry Manilow , in partnership with The Breast... be held on February 14th, 2009 at Nassau Coliseum...Monday November 10th through Ticketmaster.com or b...
Breaking Medicine News(10 mins):Health News:UJC and Jewish Federations of North America Commit $10 Million for Needs in Southern Israel 2Health News:Kevin Hutchinson Elected Vice Chair of Board of Directors for National eHealth Collaborative 2Health News:Wyeth to Present at the JP Morgan Healthcare Conference 2Health News:Barry Manilow Brings Valentine's and Music to New York With Concert to Raise Funds for Breast Cancer Research 2
...ti-clotting drugs to stroke victims could greatly ...break up clots are the only effective treatment in...er, they must be administered before brain cells d...begin within three hours of the onset of the strok...
...s created using information taken from a monkey ge... AIDS virus in a laboratory experiment. The resea...trocyclin,'' was once produced naturally in human ...of an ancient mutation. Alexander Cole, a scientis...
...re of your hair as you do of your skin, say hair e...s that the outer layer of the hair - the cuticle -... look lifeless, dry and faded.// Hair damage occur... drying to environmental pollution and sun exposur...
...ke people smarter by improving memory and brain pe... found the ability to recall remembered words impr...entists from the University of Northumbria, in New... theories. One is that chewing raises the heart b...
Other Medicine News:Health News:Scientists found ancient Human Germ Killer 2
(Date:1/6/2009)...ire/ -- Sequella, Inc., a clinical-stage biopharma...otential, announced today that SQ109, its lead dru..., was the first drug approved for evaluation in a ... Vaccine Company LLC and Quintiles Transnational. ... Allergy and Infectious Diseases (NIAID), National...
(Date:1/6/2009)...-- Pacira Pharmaceuticals, Inc., an,acute care sp...at enrollment,has been completed in two pivotal P... efficacy of a single intraoperative administratio...postoperative analgesia. , Results from the...throplasty (TKA) are expected to provide the prima...
(Date:1/5/2009)...harmaceuticals announced today that it has initiat...n kinase inhibitor, CX-4945, in patients with adva...e myeloma. The primary endpoints of the oral dose ...rance and PK properties of CX-4945 and to select t...on, multiple mechanism-related pharmacodynamic bio...
(Date:1/5/2009)...-- Women undergoing in vitro,fertilization (IVF) ...rly,pregnancy, but the intramuscular injections f...or patients. Formulations of progesterone medicat...ection or vaginal suppository may offer,similar r...h patient well-being a constant focus, Fertility P...
Breaking Medicine Technology:Sequella Lead Drug Compound SQ109 Selected for Phase 1B Clinical Trial Program 2Sequella Lead Drug Compound SQ109 Selected for Phase 1B Clinical Trial Program 3Phase III Studies of EXPAREL(TM) (DepoBupivacaine) from Pacira Complete Enrollment 2Phase III Studies of EXPAREL(TM) (DepoBupivacaine) from Pacira Complete Enrollment 3Cylene Pharmaceuticals Initiates Phase I Trial With CX-4945 -Breakthrough First-in Class Inhibitor of CK2 2Cylene Pharmaceuticals Initiates Phase I Trial With CX-4945 -Breakthrough First-in Class Inhibitor of CK2 3Fertility Physicians of Northern California Researchers Test New Forms of Progesterone Medication for Luteal Support During IVF 2Wait Educate Before You Self Medicate 14792 1Wait Educate Before You Self Medicate 14792 2Wait Educate Before You Self Medicate 14792 3Wait Educate Before You Self Medicate 14792 4Nereus Pharmaceuticals Initiates Clinical Trial of NPI 2358 in Non Small Cell Lung Cancer Following Encouraging Phase 1 Data 4104 1Nereus Pharmaceuticals Initiates Clinical Trial of NPI 2358 in Non Small Cell Lung Cancer Following Encouraging Phase 1 Data 4104 2Nereus Pharmaceuticals Initiates Clinical Trial of NPI 2358 in Non Small Cell Lung Cancer Following Encouraging Phase 1 Data 4104 3AstraZenecas Zactima to Earn Almost Five Percent Patient Share in the Treatment of Non Small Cell Lung Cancer by 2016 4102 1AstraZenecas Zactima to Earn Almost Five Percent Patient Share in the Treatment of Non Small Cell Lung Cancer by 2016 4102 2Electrophysiology Procedures for Atrial Fibrillation Treatment to Grow Over 25 25 Annually Over the Next Five Years 4100 1Electrophysiology Procedures for Atrial Fibrillation Treatment to Grow Over 25 25 Annually Over the Next Five Years 4100 2